Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!

Easy Branches

34/17 Moo 3 Chao fah west Road, Phuket, Thailand, Phuket

Call: 076 367 766

info@easybranches.com

Financial Markets

Natco Pharma rises 4% after filing ANDA for generic lung cancer drug

Natco Pharma is the first company to have filed a substantially complete ANDA for a generic cancer drug

By: business-standard.com

Aug 30 2024
0
13728 Views

Natco Pharma rises 4% after filing ANDA for generic lung cancer drug

Natco Pharma rises 4% after filing ANDA for generic lung cancer drug

Related

Lemon Tree Hotels signs new property in Uttar Pradesh

Indostar Capital Finance announces Rs 300 cr public issue of NCDs

Prestige Estates spurts on launching QIP; floor price at Rs 1,755.09/share

These stocks rallied up to 13% in run-up to Sept rollovers; what next?

Natco Pharma rises 4% after filing ANDA for generic lung cancer drug

RPP Infra Projects stock up 4% on order win from Avadi City Municipal Corp

Sammaan Capital to raise Rs 30,000 crore via NCDs, bonds

Hindustan Aeronautics announces cessation of senior management personnel

RIL share to stay sideways amid no 'big bang' AGM announcements: Analysts

US equities mixed; Dow hits new record closing

BSE SME Rapid Multimodal Logistics takes flight on listing day

Broader mkt outperforms; realty shares in demand

Lemon Tree Hotels signs new property in Uttar Pradesh